MDBKY (Medibank Pvt) YoY EBITDA Growth: 110.62% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDBKY Medibank Pvt Ltd MDBKY
68 GF Score
Price $33.82
GF Value $31.53
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Medibank Pvt YoY EBITDA Growth?

Medibank Pvt MDBKY 68 YoY EBITDA Growth is 110.62% as of Jun. 2026. GuruFocus rates MDBKY with a GF Score™ of 68/100 and a GF Value™ of $31.53 (Fairly Valued). The stock has 1 warning sign investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Medibank Pvt's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 110.62%.

Medibank Pvt's EBITDA per Share for the six months ended in Jun. 2026 was $1.43.

Medibank Pvt YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Medibank Pvt's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medibank Pvt YoY EBITDA Growth Chart

Medibank Pvt Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.03 -23.97 52.20 2.84 31.19

Medibank Pvt Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.46 3.79 1.80 -9.27 110.62
MDBKY
68GF Score
Medibank Pvt Ltd MDBKY
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medibank Pvt YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Medibank Pvt's YoY EBITDA Growth for the fiscal year that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (A: Jun. 2026 )
=(EBITDA per Share (A: Jun. 2026 )-EBITDA per Share (A: Jun. 2025 ))/ | EBITDA per Share (A: Jun. 2025 ) |
=(2.612-1.991)/ | 1.991 |
=31.19 %

Medibank Pvt's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(1.428-0.678)/ | 0.678 |
=110.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 110.62% mean?
Medibank Pvt (MDBKY) has a YoY EBITDA Growth of 110.62% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Medibank Pvt and its competitors.
Is Medibank Pvt's YoY EBITDA Growth too high?
Medibank Pvt's current YoY EBITDA Growth is 110.62%. Overall, Medibank Pvt has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's YoY EBITDA Growth compare to FNF and RYAN?
Medibank Pvt's YoY EBITDA Growth of 110.62% can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for an Insurance company?
A good YoY EBITDA Growth depends on the Insurance industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Medibank Pvt and its competitors. Medibank Pvt's current YoY EBITDA Growth is 110.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (MDBKY) is currently considered Fairly Valued. The stock's GF Value™ is $31.53, compared to a current price of $33.82 — trading 7.2% above its estimated fair value. The current YoY EBITDA Growth is 110.62%. Medibank Pvt's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Medibank Pvt (MDBKY), the current YoY EBITDA Growth is 110.62% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medibank Pvt (MDBKY) Overvalued in 2026?

Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued. The current stock price of $33.82 is trading 7.2% above its estimated GF Value™ of $31.53. GuruFocus considers Medibank Pvt to be Fairly Valued.

Key valuation signals for MDBKY:

  • YoY EBITDA Growth: 110.62%
  • GF Value™: $31.53 vs. price of $33.82 (7.2% above fair value)
  • GF Score™: 68/100 with 1 warning sign

No single metric tells the full story. See the MDBKY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medibank Pvt Business Description

Other Exchanges MDBPF:USAMPL:Australia
Address 695 Collins Street, Medibank Melbourne Hub, Level 2, Docklands, Melbourne, VIC, AUS, 3008
Medibank Private Limited is one of Australia's largest private health insurers, operating the Medibank and ahm brands. It provides private health insurance covering hospital and ancillary treatment to individuals, families, and employer groups across Australia. Beyond core health insurance, the company offers travel, life, and pet insurance, plus cover for overseas students and temporary overseas workers. Its Medibank Health division delivers healthcare services, including telehealth and in-home care, to government, corporate, and community customers in Australia and New Zealand. Revenue comes primarily from insurance premiums, supplemented by fees for health services and ancillary products. Medibank was formerly owned by the Australian government and listed on the Australian Securities Exchange in 2014. It competes with other private health funds, notably nib holdings, and remains one of the few publicly listed health insurers in Australia.
68GF Score

Get the complete analysis for MDBKY

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$33.82
Price
$31.53
GF Value